World Journal of Gastroenterology - Baishideng Publishing Group

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Yang XQ, Ye J, Li X, Li Q, Song YH. Pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome: Pathogenesis, clinical manifestations, diagnosis, treatment, and outcomes. World J Gastroenterol 2019; 25(28): 3753-3763 [PMID: 31391770 DOI: 10.3748/wjg.v25.i28.3753]
URL:	https://www.wjgnet.com/1007-9327/full/v25/i28/3753.htm

(297) (291) (0) (0) (0) (9) (9238) (77)

Number	Citing Articles
1	Li Li Zhang, Feng Zhang, Kai Wang, Yu Hu Song, Ying Zhang, Zhen Yu Zhou, Wei Jie Dai, Lei Wang, Huan Chen, Qin Yin, Yu Zheng Zhuge, Wei Zhang. Validation of Drum Tower Severity Scoring (DTSS) System for Pyrrolizidine Alkaloid‐Induced Hepatic Sinusoidal Obstruction Syndrome. Journal of Digestive Diseases 2025; 26(3-4) doi: 10.1111/1751-2980.13347
2	Sai Li, Yong Li, Chunhui Zhou, Haiping Li, Changyong Chen, Changli Peng, Tianming Wang, Fei Liu, Juxiong Xiao, Liangrong Shi. Transjugular Intrahepatic Portosystemic Shunt Benefits for Hepatic Sinusoidal Obstruction Syndrome Associated with Consumption of Gynura Segetum: a Propensity Score-Matched Analysis. CardioVascular and Interventional Radiology 2023; 46(7) doi: 10.1007/s00270-023-03451-9
3	Jianzuo Yao, Jingyi Wu, Shu Jia, Jingping Shao, Xie Zhang, Zeping Xu, Hui Zhang, Hong Li, Xiaomin Yao. Effects of bicyclol on hepatic sinusoidal obstruction syndrome induced by Gynura segetum. Journal of Clinical Laboratory Analysis 2022; 36(12) doi: 10.1002/jcla.24793
4	Zijing Song, Yisheng He, Wei Zhang, Wei Lian, Yueyang Pan, Jiang Ma, Yuxuan Zhao, Tianyang Huang, Yuzheng Zhuge, Ge Lin. Red blood cell damage defines the etiology of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids. Acta Pharmaceutica Sinica B 2026; 16(5) doi: 10.1016/j.apsb.2026.03.023
5	Yasuyuki Naito, Yuka Yoshinouchi, Yukiko Sorayama, Hiroshi Kohara, Shiro Kitano, Shinji Irie, Michiya Matsusaki. Constructing vascularized hepatic tissue by cell-assembled viscous tissue sedimentation method and its application for vascular toxicity assessment. Acta Biomaterialia 2022; 140 doi: 10.1016/j.actbio.2021.11.027
6	Mekonnen Haileselassie, Hagos Degefa Hidru, Yimer Mulugeta Agga, Mulugeta Woldu Abrha, Brhane Ayele, Hailay Gebretnsae, Ataklti Gebretsadik, Hayelom Kahsay, Tsegay Hadgu, Nega Mamo, Fisseha Ashebr, Mebrahtom Hafte Ameha, Amanuel Haile, Tesfay Belay Reda, Alem Reda, Daniel Woldemichael, Feyisa Regessa, Geremew Tasew, Getachew Tollera, Mesay Hailu, Abrha Tesfay, Samuel Aregay Gebreslassie, Abiy Girmay Haddis, Senait Tekeste Fekadu, Patrick Okumu Abok, Mussie Alemayehu, Afework Mulugeta. Burden of veno-occlusive disease in tigray region of ethiopia: Evidence from community-based survey. Scientific African 2026; 32 doi: 10.1016/j.sciaf.2026.e03358
7	Xuefeng Luo, Oana Nicoară-Farcău, Marta Magaz, Fabian Betancourt, Guillem Soy, Anna Baiges, Fanny Turon, Virginia Hernández-Gea, Juan Carlos García-Pagán. Cardio-Hepatology. 2023; doi: 10.1016/B978-0-12-817394-7.00004-8
8	Xiaofei Du, Zhenli Liu, Haibin Yu, Yu Wang, Zhengsheng Zou, Hongshan Wei, Jing Liang, Daokun Yang, Yali Liu, Jing Zhang, Calvin Q. Pan. Prognostic risk factors for patients with hepatic sinusoidal obstruction syndrome caused by pyrrolizidine alkaloids. Medicine 2023; 102(32) doi: 10.1097/MD.0000000000034698
9	Yan-yun Shu, Li-lin Hu, Ling Yang, Hui-kuan Chu, Jin Ye, Yu Jin. Rifaximin Prevents Intestinal Barrier Dysfunction and Alleviates Liver Injury in MCT-induced HSOS Mice. Current Medical Science 2023; 43(6) doi: 10.1007/s11596-023-2801-y
10	Pei Yang, Feng Zhang, Feng Wang, Yang He, Yao Wang, Lingrong Qian. Transjugular intrahepatic portosystemic shunt for hepatic sinusoidal obstruction syndrome with primary biliary cholangitis and alcoholic liver disease: a case report. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1696892
11	Gary C. Kanel. Atlas of Liver Pathology. 2024; doi: 10.1016/B978-0-323-82533-7.00007-7
12	Ruiqi Li, Lin Li, Zihao Cai, Jun Chen, Han Zhang, Si Zhao, Jingjing Tu, Chang Sun, Yani Jin, Ming Zhang, Feng Zhang, Wei Zhang, Qin Yin, Hui Xu, Hao Han, Taishun Li, Yuzheng Zhuge, Jiangqiang Xiao. Histological evaluation of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome: Correlation with Drum Tower Severity Scoring. Digestive and Liver Disease 2024; 56(7) doi: 10.1016/j.dld.2023.12.008
13	Jun-Hong Liu, Han Yang, Ling Zhang, Xing-Rong Peng, Zhen-Jie Li, Mei-Ying He, Luo-Sheng Wan, Zhong-Rong Li, Lin Zhou, Zhi-Hua Liu, Ming-Hua Qiu. Pyrrolizidine alkaloids from the seeds of Scleropyrum wallichianum. Journal of Asian Natural Products Research 2021; 23(5) doi: 10.1080/10286020.2020.1740919
14	Ziqi Wang, Haolei Han, Chen Wang, Qinqin Zheng, Hongping Chen, Xiangchun Zhang, Ruyan Hou. Hepatotoxicity of Pyrrolizidine Alkaloid Compound Intermedine: Comparison with Other Pyrrolizidine Alkaloids and Its Toxicological Mechanism. Toxins 2021; 13(12) doi: 10.3390/toxins13120849
15	Fan Wu, Jiao Yu, Hongying Gan, Heng Zhang, Deying Tian, Dan Zheng. Timing and efficacy of transjugular intrahepatic portosystemic shunt in patients with pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-01201-w
16	Yimin Mao, Shiwu Ma, Chenghai Liu, Xiaoyan Liu, Minghua Su, Dongliang Li, Yiling Li, Gongying Chen, Jun Chen, Jinjun Chen, Jingmin Zhao, Xiaoyan Guo, Jieting Tang, Yuzheng Zhuge, Qing Xie, Wen Xie, Rongtao Lai, Dachuan Cai, Qingxian Cai, Yang Zhi, Xiaoyun Li. Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update. Hepatology International 2024; 18(2) doi: 10.1007/s12072-023-10633-7
17	Gongzhen Chen, Leiming Mao, Huyan Xia, Lei Zhu, Jiamin Huang, Yingmin Lu, Xin Liu, Ting Tang. Analysis of potential risks of clinical application of Yi Dian Hong and its proprietary Chinese medicines: A review. Medicine 2024; 103(4) doi: 10.1097/MD.0000000000036860
18	Prodromos Hytiroglou, Matthew M. Yeh. MacSween's Pathology of the Liver. 2024; doi: 10.1016/B978-0-7020-8228-3.00011-9
19	Sinuo Chen, Yifan Ma, Mingyan Ji, Heming Wang, Yun Chen, Dongping Li, Hongyue Jiang, Guangqi Song, Jinglin Xia, Hong Gao. Phosphocreatine alleviates monocrotaline-induced liver injury dependent on PSRC1-regulated endoplasmic reticulum stress. Biochemical Pharmacology 2025; 237 doi: 10.1016/j.bcp.2025.116915
20	Yasuyuki Naito, Yuka Yoshinouchi, Yukiko Sorayama, Hiroshi Kohara, Shiro Kitano, Shinji Irie, Michiya Matsusaki. Constructing Vascularized Hepatic Tissue by Cell Assembled Viscous Tissue Sedimentation Method and Its Application for Vascular Toxicity Assessment. SSRN Electronic Journal 2021; doi: 10.2139/ssrn.3906842
21	Jing-Jing Tu, Han Zhang, De-Run Kong, Yan-Hong Feng, Yue-Cheng Yu, Tai-Shun Li, Feng Zhang, Wei Zhang, Hui Xu, Qin Yin, Lei Wang, Ming Zhang, Jiang-Qiang Xiao, Yu-Zheng Zhuge. Transjugular intrahepatic portosystemic shunt improves survival in anticoagulation-resistant hepatic sinusoidal obstructive syndrome patients: A multicenter retrospective study. World Journal of Hepatology 2026; 18(2): 113775 doi: 10.4254/wjh.v18.i2.113775 Abstract(135) \| Core Tip(62) \| Full Article(HTML)(282) \| Full Article (PDF)-903K(226) \| Full Article with Cover (PDF)-1201K(99) \| Full Article (XML)-103K(31) \| Audio-54K(9) \| Peer-Review Report-240K(38) \| Answering Reviewers-482K(46) \| Times Cited (0) \| Total Visits (870) \| Open
22	Jia-Yun Jiang, Yu Fu, Yan-Jiao Ou, Lei-Da Zhang. Hepatic sinusoidal obstruction syndrome induced by tacrolimus following liver transplantation: Three case reports. World Journal of Clinical Cases 2022; 10(36): 13408-13417 doi: 10.12998/wjcc.v10.i36.13408 Abstract(1353) \| Core Tip(825) \| Full Article(HTML)(3026) \| Full Article (PDF)-6158K(375) \| Full Article (Word)-4723K(72) \| Audio-608K(22) \| Peer-Review Report-228K(167) \| Answering Reviewers-127K(153) \| Times Cited (10) \| Total Visits (5119) \| Open
23	Youwen Tan, Xingbei Zhou. Anticoagulant therapy likely increases risk of bleeding in Gynura segetum-induced hepatic sinus obstruction syndrome. Medicine 2024; 103(6) doi: 10.1097/MD.0000000000035914
24	Tan-Yang Zhou, Hong-Liang Wang, Zhi-Cheng Jin, Bin Xiong, Ji Hoon Shin. Clinical challenges and transjugular intrahepatic portosystemic shunt strategies for pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome: an Asian perspective. Korean Journal of Interventional Radiology 2026; 31(1) doi: 10.64961/kjir.2026.00031
25	Jiang Ma, Mi Li, Na Li, Wood Yee Chan, Ge Lin. Pyrrolizidine Alkaloid-Induced Hepatotoxicity Associated with the Formation of Reactive Metabolite-Derived Pyrrole–Protein Adducts. Toxins 2021; 13(10) doi: 10.3390/toxins13100723
26	Yang Cheng, Lihong Gu, Xiaochun Yin, Xixuan Wang, Jiangqiang Xiao, Yi Wang, Wei Zhang, Lei Wang, Xiaoping Zou, Ming Zhang, Yuzheng Zhuge, Feng Zhang. Agreement between Wedged Hepatic Venous Pressure and Portal Pressure in Hepatic Sinusoidal Obstruction Syndrome. Journal of Personalized Medicine 2022; 13(1) doi: 10.3390/jpm13010004
27	Ziad Chebaro, Adnan Badran, Marc Maresca, Elias Baydoun, Joelle Edward Mesmar. Ethnopharmacology and therapeutic potential of Anchusa strigosa: a comprehensive review. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1301154
28	Xunjiang Wang, Wei Zhang, Yongfeng Yang, Yiran Chen, Yuzheng Zhuge, Aizhen Xiong, Li Yang, Zhengtao Wang. Blood microRNA Signatures Serve as Potential Diagnostic Biomarkers for Hepatic Sinusoidal Obstruction Syndrome Caused by Gynura japonica Containing Pyrrolizidine Alkaloids. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.627126
29	Yu-Guan Xie, Chen Xu, Hai-Bin Shi, Sheng Liu, Wei Yang, Wei Tian, Wei-Zhong Zhou. Transjugular intrahepatic portosystemic shunt for pyrrolidine-alkaloid-induced hepatic sinusoidal obstruction syndrome in a patient with situs inversus totalis and portal vein thrombus. International Journal of Gastrointestinal Intervention 2023; 12(1) doi: 10.18528/ijgii220055
30	Youwen Tan, Sainan Zheng. Clinicopathological characteristics and diagnosis of hepatic sinusoidal obstruction syndrome caused by Tusanqi – Case report and literature review. Open Medicine 2023; 18(1) doi: 10.1515/med-2023-0737
31	Xiaoxiang Sun, Zhengyuan Xie, Zheng He, Yisheng He, Zigao Zhao, Xuerong Yan, Xiangjing Song, Zijie Chen, Tao Wang, Quanrui Yue, Yiming Chen, Hanfeng Ye, Ge Lin, Hui Wang, Yu Guo. Association between pyrrolizidine alkaloids exposure and risk of abnormal serum indices—Insights from a descriptive cross-sectional study in Yunnan Province. Journal of Hazardous Materials 2024; 480 doi: 10.1016/j.jhazmat.2024.136352
32	Panpan Cen, Jiexia Ding, Jie Jin. Hepatic sinusoidal obstruction syndrome caused by the ingestion of Gynura segetum in a patient with alcoholic cirrhosis: a case report. Journal of International Medical Research 2021; 49(4) doi: 10.1177/0300060520980649
33	Chaoyang Wang, Yingliang Wang, Jianbo Zhao, Chongtu Yang, Xiaoli Zhu, Huanzhang Niu, Junhui Sun, Bin Xiong. Transjugular intrahepatic portosystemic shunt for the treatment of hepatic sinusoidal obstruction syndrome caused by pyrrolizidine alkaloids: A multicenter retrospective study. Heliyon 2024; 10(1) doi: 10.1016/j.heliyon.2023.e23455
34	Marta Magaz, Juan Carlos García-Pagán. Risk factors of poor prognosis in patients with pyrrolidine alkaloids induced hepatic sinusoidal obstruction syndrome after transjugular intrahepatic portosystemic shunt. Hepatology International 2021; 15(3) doi: 10.1007/s12072-021-10166-x
35	Qianxin Huang, Qingqiao Zhang, Hao Xu, Maoheng Zu, Jinchang Xiao, Bin Shen. Mid- to long-term outcomes of initial transjugular intrahepatic portosystemic shunt versus anticoagulation for pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome. European Journal of Gastroenterology & Hepatology 2023; 35(4) doi: 10.1097/MEG.0000000000002509
36	Bin Gao, Jingjing Zhang, Lei Zhu, Yaming Zhang. Radical total gastrectomy for gastric cancer complicated by hepatic sinusoidal obstruction syndrome: a case report. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1544400
37	Feifei Lin, Yan Ma, Anni Pan, Yang Ye, Jia Liu. Quantification of Usaramine and its N-Oxide Metabolite in Rat Plasma Using Liquid Chromatography-Tandem Mass Spectrometry. Journal of Analytical Toxicology 2022; 46(5) doi: 10.1093/jat/bkab060
38	Rolf Teschke, Xingshun Qi, Tran Dang Xuan, Axel Eickhoff. Treatment and Management of Tropical Liver Disease. 2024; doi: 10.1016/B978-0-323-87031-3.00031-7
39	Feng Dai, Wei Qiao, Zheng Kang, Yan Chen, Kang Li, Wenrong Shen, Xiuming Zhang. Clinical Features and CT Imaging Analysis of Hepatic Sinuscase-Syndrome and Budd–Chiari Syndrome. International Journal of General Medicine 2022; doi: 10.2147/IJGM.S348176
40	Haitao Shang, Chao Huang, Zhuanglong Xiao, Pengcheng Yang, Shengyan Zhang, Xiaohua Hou, Lei Zhang. Gut microbiota-derived tryptophan metabolites alleviate liver injury via AhR/Nrf2 activation in pyrrolizidine alkaloids-induced sinusoidal obstruction syndrome. Cell & Bioscience 2023; 13(1) doi: 10.1186/s13578-023-01078-4
41	Zaoqin Yu, Wei Li, Cheng Tian, Yan Cao, Chengliang Zhang. Drug-induced hepatic sinusoidal obstruction syndrome: current advances and future perspectives. Archives of Toxicology 2025; 99(3) doi: 10.1007/s00204-024-03950-9
42	Hui Zhang, Shu Jia, Lianyu Jin, Jianzuo Yao MB, Zhihong Shen, Jingyi Wu, Xiaokun Yao, Danwei Chen, Congcong Zhang, Shufang Yu, Ningwei Zhu, Lexiao Jin, Xiaomin Yao. Gynura segetum induces hepatic sinusoidal obstruction syndrome in mice by impairing autophagy. Acta Cirúrgica Brasileira 2021; 36(11) doi: 10.1590/acb361104
43	Alexandra Gangi, Tony W.H. Li, Youngyi Lim, Swati Chandla, Andrea Floris, Arash Khangholi, Maria Lauda Tomasi, Shelly C. Lu. S-Adenosylmethionine Inhibits Plasminogen-Activating Inhibitor-1 and Protects Male Mice From FOLFOX-Induced Liver Injury. Cellular and Molecular Gastroenterology and Hepatology 2025; 19(8) doi: 10.1016/j.jcmgh.2025.101513
44	Parthiban Durairaj, M. Senthil, Anand Bharathan, M. Mariappan. Tacrolimus-induced Sinusoidal Obstruction Syndrome after Liver Transplant: A Report of a Rare Case. Indian Journal of Transplantation 2024; 18(1) doi: 10.4103/ijot.ijot_97_23
45	Yuri Higashi, Seiichi Munesue, Masakazu Saeki, Ai Harashima, Kumi Kimura, Yu Oshima, Ryohei Takei, Satoshi Takada, Shinichi Nakanuma, Isamu Makino, Tetsuo Ohta, Shintaro Yagi, Hidehiro Tajima, Yasuhiko Yamamoto. Platelet aggregation elicits FasL expression and hepatocyte apoptosis in sinusoidal obstruction syndrome. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-03839-2
46	T. N. Garmanova, D. R. Markaryan, E. A. Kazachenko, G. V. Tishkin, R. V. Ishchenko. Drug-Induced Liver Injury and the Likelihood of Hepatocellular Carcinoma During Chemotherapy for Colorectal Cancer (Meta-Analysis). Russian Journal of Gastroenterology, Hepatology, Coloproctology 2025; 35(3) doi: 10.22416/1382-4376-2025-35-3-94-103
47	Minjie Jiang, Luyuan Wang, Xiaodong Du, Miaomiao Hao, Pujun Gao. Low molecular weight heparin in the treatment of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome: five case reports. Journal of International Medical Research 2020; 48(9) doi: 10.1177/0300060520961916
48	Xuan Wang, Wei Zhang, Ming Zhang, Feng Zhang, Jiangqiang Xiao, Qin Yin, Hao Han, Taishun Li, Ge Lin, Yuzheng Zhuge. Development of a Drum Tower Severity Scoring (DTSS) system for pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome. Hepatology International 2022; 16(3) doi: 10.1007/s12072-021-10293-5
49	Tongmin Huang, Xingfen Zhang, Kun Yan, Dandi Lou, Yujing He, Senjie Dai, Dingcheng Zheng, Ping Chen, Feng Wu, Lihu Gu. Transjugular intrahepatic portosystemic shunt for pyrrolidine alkaloids-induced hepatic sinusoidal obstruction syndrome: a retrospective cohort study. European Journal of Gastroenterology & Hepatology 2023; 35(9) doi: 10.1097/MEG.0000000000002591
50	Ziqi Wang, Liang Qiao, Qinqin Zheng, Haolei Han, Zuguang Li, Xiangchun Zhang, Hongping Chen. Combined Hepatotoxicity and Toxicity Mechanism of Intermedine and Lycopsamine. Toxins 2022; 14(9) doi: 10.3390/toxins14090633
51	Jiangqiang Xiao, Jingjing Tu, Han Zhang, Feng Zhang, Wei Zhang, Hui Xu, Qin Yin, Jian Yang, Hao Han, Yi Wang, Bin Zhang, Chunyan Peng, Xiaoping Zou, Ming Zhang, Yuzheng Zhuge. Risk factors of poor prognosis in patients with pyrrolidine alkaloid-induced hepatic sinusoidal obstruction syndrome after transjugular intrahepatic portosystemic shunt. Hepatology International 2021; 15(3) doi: 10.1007/s12072-020-10126-x
52	Feifei Lu, Siqi Jia, Huiyuan Lu, Haonan Zhao, Zhe Li, Yuzheng Zhuge, Fernando Gomes Romeiro, Nahum Mendez-Sanchez, Xingshun Qi. Primary Budd-Chiari syndrome versus sinusoidal obstruction syndrome: a review. Current Medical Research and Opinion 2024; 40(2) doi: 10.1080/03007995.2023.2288909
53	Qian Zheng, Haiyang Zhang. Gynura segetum induces hepatic sinusoidal obstruction syndrome in a child: A case report. Medicine 2024; 103(11) doi: 10.1097/MD.0000000000037341
54	Yu-Hu Song, Hong-Yu Xiang, Ke-Ke Si, Ze-Hui Wang, Yu Zhang, Chang Liu, Ke-Shu Xu, Xin Li. Difference between type 2 gastroesophageal varices and isolated fundic varices in clinical profiles and portosystemic collaterals. World Journal of Clinical Cases 2022; 10(17): 5620-5633 doi: 10.12998/wjcc.v10.i17.5620 Abstract(1012) \| Core Tip(806) \| Full Article(HTML)(3120) \| Full Article (PDF)-4627K(393) \| Full Article (Word)-1056K(98) \| Audio-713K(8) \| Peer-Review Report-231K(183) \| Answering Reviewers-195K(222) \| Supplementary Material-559K(197) \| Times Cited (3) \| Total Visits (5619) \| Open
55	Hongyu Xiang, Chang Liu, Zhuanglong Xiao, Li Du, Ning Wei, Fang Liu, Yuhu Song. Enoxaparin attenuates pyrrolizidine alkaloids‐induced hepatic sinusoidal obstruction syndrome by inhibiting oncostatin M expression. Liver International 2023; 43(3) doi: 10.1111/liv.15475
56	A. Laborde. Encyclopedia of Toxicology. 2024; doi: 10.1016/B978-0-12-824315-2.01145-3
57	John A. Edgar, Russell J. Molyneux, Steven M. Colegate. 1,2-Dehydropyrrolizidine Alkaloids: Their Potential as a Dietary Cause of Sporadic Motor Neuron Diseases. Chemical Research in Toxicology 2022; 35(3) doi: 10.1021/acs.chemrestox.1c00384
58	Zhenlin Huang, Zeqi Wu, Xinnan Gu, Lili Ji. Diagnosis, toxicological mechanism, and detoxification for hepatotoxicity induced by pyrrolizidine alkaloids from herbal medicines or other plants. Critical Reviews in Toxicology 2024; 54(2) doi: 10.1080/10408444.2024.2310597
59	Yong Lv, Daiming Fan, Guohong Han. Transjugular intrahepatic portosystemic shunt for portal hypertension: 30 years experience from China. Liver International 2023; 43(1) doi: 10.1111/liv.15313
60	Ning-Bo Zhao, Zi Luo, Ying Li, Rui Xia, Yu Zhang, Yi-Jun Li, Dong Zhao. Diagnostic value of ultrasonography for post-liver transplant hepatic vein complications. World Journal of Transplantation 2025; 15(2): 100373 doi: 10.5500/wjt.v15.i2.100373 Abstract(513) \| Core Tip(463) \| Full Article(HTML)(1852) \| Full Article (PDF)-16456K(217) \| Full Article with Cover (PDF)-16823K(211) \| Full Article (XML)-86K(97) \| Audio-1207K(14) \| Peer-Review Report-220K(129) \| Answering Reviewers-63K(130) \| Times Cited (0) \| Total Visits (2853) \| Open
61	Ju Wang, Xuanzhen Zhang, Song Tan, Ping Zhong, Jian Zhu, Weiwen Yang. Hepatic sinusoidal obstruction syndrome caused by Gynura japonica once misdiagnosed as pancreatitis: a case report and review of literature. Journal of Medical Case Reports 2026; 20(1) doi: 10.1186/s13256-026-05875-6
62	Zhenlin Huang, Zeqi Wu, Jingnan Zhang, Keke Wang, Qing Zhao, Minwei Chen, Shihao Yan, Qian Guo, Yun Ma, Lili Ji. Andrographolide attenuated MCT-induced HSOS via regulating NRF2-initiated mitochondrial biogenesis and antioxidant response. Cell Biology and Toxicology 2023; 39(6) doi: 10.1007/s10565-023-09832-7
63	Yaru Tong, Ming Zhang, Zexue Qi, Wei Wu, Jinjun Chen, Fuliang He, Hao Han, Pengxu Ding, Guangchuan Wang, Yuzheng Zhuge. Hepatic Venous Occlusion Type of Budd–Chiari Syndrome versus Pyrrolizidine Alkaloid-Induced Hepatic Sinusoidal Obstructive Syndrome: A Multi-Center Retrospective Study. Journal of Personalized Medicine 2023; 13(4) doi: 10.3390/jpm13040603
64	Rolf Teschke, Noudeng Vongdala, Nguyen Van Quan, Tran Ngoc Quy, Tran Dang Xuan. Metabolic Toxification of 1,2-Unsaturated Pyrrolizidine Alkaloids Causes Human Hepatic Sinusoidal Obstruction Syndrome: The Update. International Journal of Molecular Sciences 2021; 22(19) doi: 10.3390/ijms221910419
65	Xiaoqian Yang, Ping Lei, Yuhu Song, Zhenyu Fei, Yan Ai, Haitao Shang, Tao Bai, Jin Ye, Xin Li. Quantitative CT assessment by histogram and volume ratio in pyrrolizidines alkaloids-induced hepatic sinusoidal obstruction syndrome. European Journal of Radiology 2021; 138 doi: 10.1016/j.ejrad.2021.109632
66	Ying Liu, Li-Ying Sun, Zhi-Jun Zhu, Lin Wei, Wei Qu, Zhi-Gui Zeng. Is sinusoidal obstructive syndrome a recurrent disease after liver transplantation? A case report . World Journal of Clinical Cases 2021; 9(2): 489-495 doi: 10.12998/wjcc.v9.i2.489 Abstract(1412) \| Core Tip(1074) \| Full Article(HTML)(2653) \| Full Article (PDF)-12217K(574) \| Full Article (Word)-750K(311) \| Audio-476K(8) \| Peer-Review Report-238K(247) \| Answering Reviewers-62K(290) \| Times Cited (0) \| Total Visits (4971) \| Open
67	Chengxiong Zhang, Zehui Wu, Fengping Wang, Lianghui Shi. Hepatic sinusoidal obstruction syndrome after oral intake of Gynura segetum. Asian Journal of Surgery 2021; 44(7) doi: 10.1016/j.asjsur.2021.04.015
68	Ana Catarina Sousa, Cláudia Ribeiro, Virgínia M.F. Gonçalves, Inês Pádua, Sandra Leal. Chromatographic Methods for Detection and Quantification of Pyrrolizidine Alkaloids in Flora, Herbal Medicines, and Food: An Overview. Critical Reviews in Analytical Chemistry 2024; 54(8) doi: 10.1080/10408347.2023.2218476
69	Adelina Staicu, Roxana Popa-Stanila, Camelia Albu, Alexandra Chira, Roxana Constantin, Dan Boitor-Borza, Mihai Surcel, Ioana Cristina Rotar, Gheorghe Cruciat, Daniel Muresan. Neonatal Hemochromatosis: Systematic Review of Prenatal Ultrasound Findings—Is There a Place for MRI in the Diagnostic Process?. Journal of Clinical Medicine 2023; 12(7) doi: 10.3390/jcm12072679
70	Shu-Yue Wang, Si-Qi Yin, Jie-Ying Yang, Ming-Yan Ji, Xiao-Qing Zeng, Sheng-Xiang Rao, Min-Zhi Lv, Jie Bao, Man-Ning Wang, Hong Gao. Development and validation of a deep-learning-based diagnostic model for drug-induced liver injury using computed tomography images. World Journal of Gastroenterology 2026; 32(15): 114778 doi: 10.3748/wjg.v32.i15.114778 Abstract(66) \| Core Tip(58) \| Full Article(HTML)(159) \| Full Article (PDF)-1800K(59) \| Full Article with Cover (PDF)-2172K(18) \| Full Article (XML)-102K(15) \| Audio-181K(5) \| Peer-Review Report-263K(18) \| Answering Reviewers-899K(24) \| Supplementary Material-983K(19) \| Times Cited (0) \| Total Visits (365) \| Open
71	Josephin Glück, Marcus Henricsson, Albert Braeuning, Stefanie Hessel-Pras. The Food Contaminants Pyrrolizidine Alkaloids Disturb Bile Acid Homeostasis Structure-Dependently in the Human Hepatoma Cell Line HepaRG. Foods 2021; 10(5) doi: 10.3390/foods10051114
72	Fang Liu, Xinxin Rong, Hui Guo, Dong Xu, Chang Liu, Lingling Meng, Xiaoqian Yang, Tingting Guo, Xuefeng Kan, Yuhu Song. Clinical characteristics, CT signs, and pathological findings of Pyrrolizidine alkaloids-induced sinusoidal obstructive syndrome: a retrospective study. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-1180-0
73	David Ricardo da Conceição Marçal Alves Nunes, Cristina Sofia de Jesus Monteiro, Jorge Luiz dos Santos. Herb-Induced Liver Injury—A Challenging Diagnosis. Healthcare 2022; 10(2) doi: 10.3390/healthcare10020278
74	Wencheng Liu, Yanbin Cheng, Xue Han, Junlin Xia, Qingyu Wei, Bing Chang, Quansheng Li. Rivaroxaban alleviates hepatic sinusoidal obstruction syndrome in mice by modulating the gut microbiota and inhibiting the PI3K/Akt signaling pathway. Frontiers in Microbiology 2025; 16 doi: 10.3389/fmicb.2025.1607131